Analysts Offer Insights on Healthcare Companies: Mallinckrodt (ALBO) and Albireo Pharma Inc (ALBO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Mallinckrodt (NYSE: MNK) and Albireo Pharma Inc (NASDAQ: ALBO).

Mallinckrodt (NYSE: MNK)

Mizuho Securities analyst Irina Rivkind Koffler reiterated a Hold rating on Mallinckrodt (NYSE: MNK) today and set a price target of $15. The company’s shares opened today at $16.08, close to its 52-week low of $11.65.

Rivkind Koffler noted:

“We reiterate our Neutral rating and $15 PT after a strong 1Q:18 but are cautious heading into a pipeline read-out in a rare disease that is expected mid-year.”

According to TipRanks.com, Koffler is a 5-star analyst with an average return of 12.5% and a 49.7% success rate. Koffler covers the Healthcare sector, focusing on stocks such as Pacira Pharmaceuticals, Adamas Pharmaceuticals, and Eagle Pharmaceuticals.

Currently, the analyst consensus on Mallinckrodt is Hold and the average price target is $19.27, representing a 19.8% upside.

In a report issued on May 4, Wells Fargo also maintained a Hold rating on the stock with a $15 price target.

See today’s analyst top recommended stocks >>

Albireo Pharma Inc (NASDAQ: ALBO)

Wedbush analyst Liana Moussatos reiterated a Buy rating on Albireo Pharma Inc (NASDAQ: ALBO) today and set a price target of $69. The company’s shares opened today at $32.77.

According to TipRanks.com, Moussatos is a 4-star analyst with an average return of 10.8% and a 44.7% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as Allena Pharmaceuticals Inc, Global Blood Therapeutics, and Catabasis Pharmaceuticals.

Currently, the analyst consensus on Albireo Pharma Inc is Strong Buy and the average price target is $54.33, representing a 65.8% upside.

In a report released yesterday, Needham also assigned a Buy rating to the stock with a $50 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.